Synthesis of lipophilic 1-deoxygalactonojirimycin derivatives as D-galactosidase inhibitors

Georg Schitter, Elisabeth Scheucher, Andreas J. Steiner, Arnold E. Stütz, Martin Thonhofer, Chris A. Tarling, Stephen G. Withers, Jacqueline Wicki, Katrin Fantur, Eduard Paschke, Don J. Mahuran, Brigitte A. Rigat, Michael Tropak and Tanja M. Wrodnigg
Beilstein J. Org. Chem. 2010, 6, No. 21. https://doi.org/10.3762/bjoc.6.21

Supporting Information

Supporting Information File 1: Full experimental details and characterisation data
Format: PDF Size: 120.7 KB Download

Cite the Following Article

Synthesis of lipophilic 1-deoxygalactonojirimycin derivatives as D-galactosidase inhibitors
Georg Schitter, Elisabeth Scheucher, Andreas J. Steiner, Arnold E. Stütz, Martin Thonhofer, Chris A. Tarling, Stephen G. Withers, Jacqueline Wicki, Katrin Fantur, Eduard Paschke, Don J. Mahuran, Brigitte A. Rigat, Michael Tropak and Tanja M. Wrodnigg
Beilstein J. Org. Chem. 2010, 6, No. 21. https://doi.org/10.3762/bjoc.6.21

How to Cite

Schitter, G.; Scheucher, E.; Steiner, A. J.; Stütz, A. E.; Thonhofer, M.; Tarling, C. A.; Withers, S. G.; Wicki, J.; Fantur, K.; Paschke, E.; Mahuran, D. J.; Rigat, B. A.; Tropak, M.; Wrodnigg, T. M. Beilstein J. Org. Chem. 2010, 6, No. 21. doi:10.3762/bjoc.6.21

Download Citation

Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window below.
Citation data in RIS format can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Zotero.

Citations to This Article

Up to 20 of the most recent references are displayed here.

Scholarly Works

  • Ashmus, R. A.; Wang, Y.; González-Cuesta, M.; King, D. T.; Tiet, B.; Gilormini, P.-A.; Fernández, J. M. G.; Mellet, C. O.; Britton, R.; Vocadlo, D. J. Rational design of cell active C2-modified DGJ analogues for the inhibition of human α-galactosidase A (GALA). Organic & biomolecular chemistry 2021, 19, 8057–8062. doi:10.1039/d1ob01526e
  • Mohamed, F. E.; M, A. S.; Ghattas, M. A.; Al-Gazali, L.; Al-Dirbashi, O. Y.; Al-Jasmi, F.; Ali, B. R. The pharmacological chaperone N-n-butyl-deoxygalactonojirimycin enhances β-galactosidase processing and activity in fibroblasts of a patient with infantile GM1-gangliosidosis. Human genetics 2020, 139, 657–673. doi:10.1007/s00439-020-02153-3
  • Flick, A. C.; Ding, H. X.; Leverett, C. A.; Fink, S. J.; O’Donnell, C. J. Synthetic Approaches to New Drugs Approved During 2016. Journal of medicinal chemistry 2018, 61, 7004–7031. doi:10.1021/acs.jmedchem.8b00260
  • Meanwell, M.; Sutherland, M.; Britton, R. Application of sequential proline-catalyzed α-chlorination and aldol reactions in the total synthesis of 1-deoxygalactonojirimycin. Canadian Journal of Chemistry 2018, 96, 144–147. doi:10.1139/cjc-2017-0318
  • Convertino, M.; Das, J.; Dokholyan, N. V. Pharmacological Chaperones: Design and Development of New Therapeutic Strategies for the Treatment of Conformational Diseases. ACS chemical biology 2016, 11, 1471–1489. doi:10.1021/acschembio.6b00195
  • Sánchez-Fernández, E. M.; Fernández, J. M. G.; Mellet, C. O. Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: lessons from Gaucher, GM1-gangliosidosis and Fabry diseases. Chemical communications (Cambridge, England) 2016, 52, 5497–5515. doi:10.1039/c6cc01564f
  • Alcaide, A.; Trapero, A.; Pérez, Y.; Llebaria, A. Galacto configured N-aminoaziridines: a new type of irreversible inhibitor of β-galactosidases. Organic & biomolecular chemistry 2015, 13, 5690–5697. doi:10.1039/c5ob00532a
  • Yu, Y.; Mena-Barragán, T.; Higaki, K.; Johnson, J. L.; Drury, J. E.; Lieberman, R. L.; Nakasone, N.; Ninomiya, H.; Tsukimura, T.; Sakuraba, H.; Suzuki, Y.; Nanba, E.; Mellet, C. O.; Fernández, J. M. G.; Ohno, K. Molecular basis of 1-deoxygalactonojirimycin arylthiourea binding to human α-galactosidase a: pharmacological chaperoning efficacy on Fabry disease mutants. ACS chemical biology 2014, 9, 1460–1469. doi:10.1021/cb500143h
  • Biela-Banaś, A.; Gallienne, E.; Front, S.; Martin, O. R. Stereoselective synthesis of 1-C-alkyl iminogalactitol derivatives, potential chaperones for galactosidase-linked LSDs: a real challenge. Tetrahedron Letters 2014, 55, 838–841. doi:10.1016/j.tetlet.2013.12.024
  • Galvis, J.; González, J.; Torrente, D.; Velasco, H.; Barreto, G. E. In silico Analysis of Iduronate 2 Sulfatase Mutations in Colombian Patients with Hunter Syndrome (MPSII). Advances in Intelligent Systems and Computing; Springer International Publishing, 2014; pp 205–212. doi:10.1007/978-3-319-01568-2_30
  • Boyd, R.; Lee, G.; Rybczynski, P. J.; Benjamin, E. R.; Khanna, R.; Wustman, B.; Valenzano, K. J. Pharmacological Chaperones as Therapeutics for Lysosomal Storage Diseases. Journal of medicinal chemistry 2013, 56, 2705–2725. doi:10.1021/jm301557k
  • Du, Y.; Ye, H.; Gill, T.; Wang, L.; Guo, F.; Cuconati, A.; Guo, J.-T.; Block, T. M.; Chang, J.; Xu, X. N-Alkyldeoxynojirimycin derivatives with novel terminal tertiary amide substitution for treatment of bovine viral diarrhea virus (BVDV), Dengue, and Tacaribe virus infections. Bioorganic & medicinal chemistry letters 2013, 23, 2172–2176. doi:10.1016/j.bmcl.2013.01.108
  • Aymami, J.; Barril, X.; Rodríguez-Pascau, L.; Martinell, M. Pharmacological chaperones for enzyme enhancement therapy in genetic diseases. Pharmaceutical patent analyst 2012, 2, 109–124. doi:10.4155/ppa.12.74
  • Lee, J. C.; Francis, S.; Dutta, D.; Gupta, V.; Yang, Y.; Zhu, J.-Y.; Tash, J. S.; Schönbrunn, E.; Georg, G. I. Synthesis and evaluation of eight- and four-membered iminosugar analogues as inhibitors of testicular ceramide-specific glucosyltransferase, testicular β-glucosidase 2, and other glycosidases. The Journal of organic chemistry 2012, 77, 3082–3098. doi:10.1021/jo202054g
  • Lindhorst, T. K. Synthesis in the glycosciences II. Beilstein journal of organic chemistry 2012, 8, 411–412. doi:10.3762/bjoc.8.45
  • Valenzano, K. J.; Khanna, R.; Powe, A. C.; Boyd, R.; Lee, G.; Flanagan, J. J.; Benjamin, E. R. Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders. Assay and drug development technologies 2011, 9, 213–235. doi:10.1089/adt.2011.0370
  • Fröhlich, R. F.; Furneaux, R. H.; Mahuran, D. J.; Saf, R.; Stütz, A. E.; Tropak, M. B.; Wicki, J.; Withers, S. G.; Wrodnigg, T. M. 1-Deoxy-d-galactonojirimycins with dansyl capped N-substituents as β-galactosidase inhibitors and potential probes for GM1 gangliosidosis affected cell lines. Carbohydrate research 2011, 346, 1592–1598. doi:10.1016/j.carres.2011.05.010
  • Stütz, A. E.; Wrodnigg, T. M. Imino sugars and glycosyl hydrolases: historical context, current aspects, emerging trends. Advances in carbohydrate chemistry and biochemistry 2011, 66, 187–298. doi:10.1016/b978-0-12-385518-3.00004-3

Patents

  • DU YANMING; XU XIAODONG; YE HONG; CHANG JINHONG; BLOCK TIMOTHY M. Alkylated imino sugars exhibiting glucosidase inhibition and their method of use. US 10376502 B2, Aug 13, 2019.
  • MALVESTITI ANDREA; BRUNOLDI ENRICO; ATTOLINO EMANUELE. Synthesis of an azasugar and the intermediates thereof. US 9708263 B2, July 18, 2017.
  • MALVESTITI ANDREA; BRUNOLDI ENRICO; ATTOLINO EMANUELE. SYNTHESIS OF AN AZASUGAR AND THE INTERMEDIATES THEREOF. EP 3081555 A1, Oct 19, 2016.
  • MALVESTITI ANDREA; BRUNOLDI ENRICO; ATTOLINO EMANUELE. SINTESI DI UN AZAZUCCHERO E I SUOI INTERMEDI. IT UB20150176 A1, Oct 17, 2016.
  • ATTOLINO EMANUELE; MALVESTITI ANDREA. Synthesis of a glycosyltransferase inhibitor. US 9079856 B2, July 14, 2015.
  • ATTOLINO EMANUELE; MALVESTITI ANDREA. SINTESI DI UN INIBITORE DELLE GLICOSILTRANSFERASI. IT MI20122090 A1, June 7, 2014.
  • DU YANMING; XU XIAODONG; YE HONG; CHANG JINHONG; BLOCK TIMOTHY M. NOVEL ALKYLATED IMINO SUGARS EXHIBITING GLUCOSIDASE INHIBITION AND THEIR METHOD OF USE. WO 2013148791 A1, Oct 3, 2013.
Other Beilstein-Institut Open Science Activities